James Pring

504 total citations
6 papers, 268 citations indexed

About

James Pring is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, James Pring has authored 6 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Hematology and 1 paper in Molecular Biology. Recurrent topics in James Pring's work include Immune Cell Function and Interaction (5 papers), Hematopoietic Stem Cell Transplantation (3 papers) and T-cell and B-cell Immunology (3 papers). James Pring is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Hematopoietic Stem Cell Transplantation (3 papers) and T-cell and B-cell Immunology (3 papers). James Pring collaborates with scholars based in United States. James Pring's co-authors include Jeffrey M. Venstrom, Katharine C. Hsu, Junli Yu, Xiaorong Liu, Richard J. O’Reilly, Bo Dupont, Effie W. Petersdorf, Mari Malkki, Stephen R. Spellman and Ted Gooley and has published in prestigious journals such as Blood, Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation.

In The Last Decade

James Pring

6 papers receiving 265 citations

Peers

James Pring

IMMUN

HEMAT

ONCOL

MB

NEURO

Ilse Houtenbos Netherlands

Ignacio Casas-Avilés Spain

Eleanor Berrie United Kingdom

María C. Viguria Spain

María Jesús Blanchard Spain

Andrea Brinkmann Germany

Joseph Wahle United States

Sami Chu United States

Valentina Gambacorta Italy

Caroline Sola France

Ilse Houtenbos Netherlands

James Pring

145 ×0.6

IMMUN

31 ×0.2

HEMAT

100 ×1.4

ONCOL

51 ×3.0

MB

3 ×0.3

NEURO

Citations per year, relative to James Pring James Pring (= 1×) peers Ilse Houtenbos

Countries citing papers authored by James Pring

Since Specialization

Citations

This map shows the geographic impact of James Pring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Pring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Pring more than expected).

Fields of papers citing papers by James Pring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Pring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Pring. The network helps show where James Pring may publish in the future.

Co-authorship network of co-authors of James Pring

This figure shows the co-authorship network connecting the top 25 collaborators of James Pring. A scholar is included among the top collaborators of James Pring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Pring. James Pring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Anandasabapathy, Niroshana, Gaëlle Breton, Arlene Hurley, et al.. (2015). Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplantation. 50(7). 924–930. 81 indexed citations

2.

Anandasabapathy, Niroshana, Arlene Hurley, Gaëlle Breton, et al.. (2013). A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers. Biology of Blood and Marrow Transplantation. 19(2). S112–S113. 2 indexed citations

3.

Caskey, Marina, Christine Trumpfheller, Sarah Pollak, et al.. (2012). In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers. Retrovirology. 9(S2). 1 indexed citations

4.

Venstrom, Jeffrey M., Ted Gooley, Stephen R. Spellman, et al.. (2010). Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood. 115(15). 3162–3165. 80 indexed citations

5.

Yu, Junli, Jeffrey M. Venstrom, Xiaorong Liu, et al.. (2009). Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell–depleted allogeneic hematopoietic cell transplantation. Blood. 113(16). 3875–3884. 103 indexed citations

6.

Venstrom, Jeffrey M., Ted Gooley, Stephen R. Spellman, et al.. (2009). Donor KIR 3DS1 is Associated with Less Acute GvHD Following Unrelated Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 15(2). 14–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact